14部委为今年医药反腐纠风划重点，系统纠治医疗服务乱象

Core Viewpoint - The article emphasizes the need for a "zero tolerance" approach towards unethical behavior among medical personnel, highlighting the importance of maintaining public interest, patient rights, and the integrity of the healthcare industry [1][7]. Group 1: Regulatory Measures - The National Health Commission and 14 other ministries have issued a notification to continue anti-corruption efforts in the medical field, focusing on preventing the resurgence of unethical practices [2]. - The notification outlines a comprehensive approach to address corruption in the pharmaceutical procurement and medical service sectors, emphasizing the need for enhanced oversight and accountability [3][8]. - A "penetrating audit" approach will be implemented to cover the entire pharmaceutical supply chain, ensuring compliance and preventing conflicts of interest [3][4]. Group 2: Focus Areas for Governance - Key areas of focus include drug production, high-value medical consumables, medical equipment, and the management of healthcare institutions [3][5]. - The notification stresses the importance of protecting patient privacy and addressing illegal activities in areas such as genetic testing, assisted reproduction, and medical aesthetics [6][8]. - The regulation of internet medical practices will be intensified, targeting illegal online prescriptions and fraudulent medical advertising [6][8]. Group 3: Strengthening Ethical Standards - The notification calls for strict enforcement of ethical standards within medical institutions, with a focus on daily education and guidance for medical staff [7]. - A mechanism will be explored to link ethical evaluations with job appointments, title assessments, and compensation distribution, fostering a transparent industry environment [7][8]. - The emphasis on "zero tolerance" for unethical behavior aims to protect public interests and uphold the rights of patients [1][7].